04/22/2024
3:15 PM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T | |
04/16/2024
3:56 PM | Arjuna Capital (Filed by)
Vertex Pharmaceuticals (Subject)
| Form PX14A6G | |
04/11/2024
3:08 PM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/11/2024
6:13 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
6:17 AM | Vertex Pharmaceuticals (Subject)
| Form SC TO-C | |
04/10/2024
4:22 PM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/10/2024
11:14 AM | Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
|
04/04/2024
3:05 PM | Vertex Pharmaceuticals (Filer)
| Form ARS | |
02/27/2024
3:44 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:37 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:24 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
12:19 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
10:25 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
10:10 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
9:44 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
9:52 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
9:26 AM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:28 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:16 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:43 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:49 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:38 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:26 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:29 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
10:38 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
9:44 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
9:52 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
9:16 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:50 AM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:43 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
10:03 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
10:29 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:57 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:32 AM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:22 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:22 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
10:19 AM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
4:11 PM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
4:34 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:23 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
12:42 PM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Thousands of investors use this no cost solution | Do you? (Ad) In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve.
Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media. Simply tap here now to subscribe and start getting "Insider Financial Advantage" |
02/12/2024
12:24 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
11:44 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
10:32 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
9:32 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
8:52 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
5:19 PM | Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
3:38 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:40 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:43 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:45 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:47 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:20 PM | Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:10 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:09 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
3:06 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:56 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
3:17 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
9:32 AM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
3:33 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
11:51 AM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
3:27 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
2:23 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
1:46 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
11:59 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:03 PM | Thornberry Nancy (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/06/2023
3:07 PM | Thornberry Nancy (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:14 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
3:07 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
10:54 AM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
9:26 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2023
9:29 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
2:51 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
3:16 PM | Vertex Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
3:05 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
10:50 AM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2023
10:33 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023
3:13 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/19/2023
3:18 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:17 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:19 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:17 PM | MCKENZIE DIANA (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
9:53 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2023
10:00 AM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2023
3:14 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
3:44 PM | Lagarde Michel (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
3:38 PM | Lagarde Michel (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/06/2023
1:53 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/05/2023
3:30 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
10:11 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad) “Titan of Tech” Bets Big on Tiny AI Company
He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal…
But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him |
10/02/2023
11:34 AM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/21/2023
3:15 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
8:55 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:29 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:23 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
2:03 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2023
3:14 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
11:37 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023
3:05 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
